|
581 |
The Coming Era of Quadrivalent Human Influenza Vaccines
Enthalten in Drugs Bd. 72, 10.1.2013, Nr. 17, date:12.2012: 2177-2185
|
|
|
|
582 |
The Cost and Incidence of Prescribing Errors Among Privately Insured HIV Patients
Enthalten in PharmacoEconomics Bd. 28, 23.9.2012, Nr. 1, date:1.2010: 23-34
|
|
|
|
583 |
The Cost Effectiveness of Genetic Testing for CYP2C19 Variants to Guide Thienopyridine Treatment in Patients with Acute Coronary Syndromes
Enthalten in PharmacoEconomics Bd. 30, 27.12.2012, Nr. 11, date:11.2012: 1067-1084
|
|
|
|
584 |
The Cost Effectiveness of Newer Epilepsy Treatments
Enthalten in PharmacoEconomics Bd. 30, 27.12.2012, Nr. 10, date:10.2012: 903-923
|
|
|
|
585 |
The Cost Effectiveness of Rufinamide in the Treatment of Lennox-Gastaut Syndrome in the UK
Enthalten in PharmacoEconomics Bd. 28, 17.9.2012, Nr. 3, date:3.2010: 185-199
|
|
|
|
586 |
The Cost of Disability and Medically Related Absenteeism Among Employees with Multiple Sclerosis in the US
Enthalten in PharmacoEconomics Bd. 27, 17.9.2012, Nr. 8, date:8.2009: 681-691
|
|
|
|
587 |
The Economics of a ‘Liberated’ NHS
Enthalten in PharmacoEconomics Bd. 28, 17.9.2012, Nr. 12, date:12.2010: 1075-1078
|
|
|
|
588 |
The Effect of Budesonide/Formoterol Pressurized Metered-Dose Inhaler on Predefined Criteria for Worsening Asthma in Four Different Patient Populations with Asthma
Enthalten in Drugs in R & D Bd. 12, 27.11.2012, Nr. 1, date:3.2012: 9-14
|
|
|
|
589 |
The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients
Enthalten in Clinical pharmacokinetics Bd. 50, 30.9.2012, Nr. 2, date:2.2011: 99-110
|
|
|
|
590 |
The Efficacy and Tolerability of Bupropion in the Treatment of Major Depressive Disorder
Enthalten in Clinical drug investigation Bd. 31, 24.8.2012, Nr. 1, date:10.2011: 5-17
|
|
Administration
